Tomorrow's Drugs Today
evotec
[search1]
  • About us
    • Renovis Merger
    • Senior Management
    • Supervisory Board
    • Scientific Advisory Board
    • Evotec Worldwide
  • Our Platform
    • Fragment-based Drug Discovery
    • Assay Development & Screening
    • Compound Libraries
    • Medicinal Chemistry
  • Our Pipeline
  • Partners
  • Investors
    • Evotec Stock
    • Financial Key Figures Analysts
    • Financial Reports Annual General Meeting
    • SEC Filings Corporate Governance
    • Webcasts Annual Document
  • News & Events
    • Adhoc Releases
    • News Releases
    • Events Calendar
    • Sign up for News & Events
  • Careers
    • Vacancies
    • Life at Evotec
    • Graduate Recruitment
  • Contact Us
  • Deutsch
  • Home
[search1]
We strive to be the premier drug discovery and development partner for pharmaceutical and biotechnology companies
  • Quick Links
  • Renovis Merger
  • Fragment Based Drug Discovery
  • Discovery Projects
  • Clinical Pipeline

Recent News

Aug 06, 2008

Evotec Reports Results of the First Half of 2008

Aug 01, 2008

Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist under Partnership with Pfizer Inc.

Next Event

28 Aug 2008

Annual General Meeting/Ordentliche Hauptversammlung

Webcast

H1 conference call
August 6, 2008
02.00 pm CET

[search3]
  • Search
  • Disclaimer
  • Privacy Policy
  • Imprint
  • Download Center
  • Accessibility
  • RSS

© 2008 Evotec all rights reserved

[search3]